ResMed Inc. |
Market Cap (5-Nov) $47,021,662,208 (13th) |
Close (30-Jun) $32.81 |
Volume (30-Jun) 1,098,777 |
Shortsold (30-Oct) 3,682,574 (0.65%) (308th) |
|
52w High $39.61 |
52w Low $25.42 |
P/E 19.57 |
EPS 1.59 |
[ARTICLE] ResMed downplays Ozempic disruption fears as sales beat forecasts
A news article has been posted about ResMed Inc. on the AFR. The article was published around , on 25 October 2024 at 5:20pm.
Chief executive Mick Farrell says the company has only scratched the service in global demand for sleeping disorder devices.
Read ArticleRMD was $32.81 at the close of trade on 30 June 2023
| Recent Articles about ASX:RMD | |
|---|---|
| 28-Oct | AFIC NTA - Australian Foundation Investment Company
company-announcements.afr.com |
| 26-Oct | Issued October 2026 - AFR
company-announcements.afr.com |
| 26-Oct | 2026 Annual General Meeting (AGM) Chairman's Address and ...
company-announcements.afr.com |
| 23-Oct | FORM 4 - AFR
company-announcements.afr.com |
| 21-Oct | ASX Announcement - Australian United Investment Company Limited
company-announcements.afr.com |
| 21-Oct | FORM 4 - AFR
company-announcements.afr.com |
| 21-Oct | Appendix 4A - Statement of CDIs on issue - AFR
company-announcements.afr.com |
| 20-Sep | ResMed ASX Deferral of Conversions Announcement - AFR
company-announcements.afr.com |
| 18-Sep | PolyNovo Appoints Dean Phizacklea and Andrew Price as Non ...
company-announcements.afr.com |
| 18-Sep | Australian United Investment Company Limited - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about ResMed Inc., including others on the AFR, on the media page.
If you were already registered, log in here.